Clinical Trial Update: Compare Captisol-Enabled (CE) Budesonide + Azelastine Nasal Solution and Rhinocort Aqua + Astelin in an Environmental Exposure Chamber (EEC) Study of Allergic Rhinitis [Phase 2]

View source ↗

Summary

Phase 2 environmental exposure chamber study comparing Captisol-enabled budesonide plus azelastine nasal solution with Rhinocort Aqua plus astelin in seasonal a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Seasonal Allergic Rhinitis

Drugs mentioned

• AZELASTINE (Azelastine)
• Budesonide (BUDESONIDE)

Snippet

Sponsor: Ligand Pharmaceuticals | Conditions: Seasonal Allergic Rhinitis | Phase 2 | Status: COMPLETED